knowledge -WSS

knowledge

author：explore 2025-09-29 22:50:03 - browse：83144

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： CDC overhauls leadership of center that led response to Covid

leisure time

WSS

White House drug shortages task force keeps mum with Congress

Who are the detained American citizens released from prison in Iran?

Secretariat’s lessons for human medicine

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Abridge raises $150m as clinical notes automation market heats up

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

focus

knowledge

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

MD Anderson's Padmanee Sharma responds to research credit suit

Apple is now the first public company to be valued at $3 trillion

Abridge raises $150m as clinical notes automation market heats up

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Secretariat’s lessons for human medicine

How to save PrEP access — and even expand it

Hospitals are piloting generative AI tools as regulators play catch

In Memoriam: Notable people who died in 2023

Flagship Pioneering startup Sonata Therapeutics lays off 21

focus

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Medicare Advantage enrollment hits roughly 33.4 million

Pharma budget tightening trickles down to Doximity

Reporting on presidential health from Reagan to Trump and Biden

Pharma budget tightening trickles down to Doximity

leisure time

hotspot

leisure time

explore